Literature DB >> 1706983

5-HT1A partial agonists. What is their future?

D A Glitz1, R Pohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1706983     DOI： 10.2165/00003495-199141010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  107 in total

1.  Brain biogenic amine depletion and mood.

Authors:  J Mendels; A Frazer
Journal:  Arch Gen Psychiatry       Date:  1974-04

2.  Recent advances in anxiolytic therapy.

Authors:  K Rickels
Journal:  J Clin Psychiatry       Date:  1981-11       Impact factor: 4.384

3.  Clinical profile of gepirone, a nonbenzodiazepine anxiolytic.

Authors:  N E Harto; R J Branconnier; K F Spera; E C Dessain
Journal:  Psychopharmacol Bull       Date:  1988

4.  A 5-HT1A ligand with both antidepressant and anxiolytic properties.

Authors:  J M Cott; N M Kurtz; D S Robinson; S P Lancaster; J E Copp
Journal:  Psychopharmacol Bull       Date:  1988

5.  Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone.

Authors:  J P Feighner; J B Cohn
Journal:  Neuropsychobiology       Date:  1989       Impact factor: 2.328

6.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  J A Engel; S Hjorth; K Svensson; A Carlsson; S Liljequist
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

7.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.

Authors:  P Thorén; M Asberg; B Cronholm; L Jörnestedt; L Träskman
Journal:  Arch Gen Psychiatry       Date:  1980-11

8.  L-5-hydroxytryptophan in the treatment of anxiety disorders.

Authors:  R S Kahn; H G Westenberg
Journal:  J Affect Disord       Date:  1985 Mar-Apr       Impact factor: 4.839

9.  Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.

Authors:  T R Insel; D L Murphy; R M Cohen; I Alterman; C Kilts; M Linnoila
Journal:  Arch Gen Psychiatry       Date:  1983-06

10.  Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo.

Authors:  J C Pecknold; M Matas; B G Howarth; C Ross; R Swinson; C Vezeau; W Ungar
Journal:  Can J Psychiatry       Date:  1989-11       Impact factor: 4.356
View more
  3 in total

1.  Anticonflict and discriminative stimulus effects in the pigeon of a new methoxy-chroman 5-HT1A agonist, (+)S 20244 and its enantiomers (+)S 20499 and (-)S 20500.

Authors:  J E Barrett; E H Gamble; L Zhang; B Guardiola-Lemaitre
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

2.  (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.

Authors:  T Jolas; S Haj-Dahmane; L Lanfumey; C M Fattaccini; E J Kidd; J Adrien; H Gozlan; B Guardiola-Lemaitre; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

Review 3.  Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.

Authors:  J R Steinberg
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.